Polanco, M.; Gárate, G.; Sánchez-GudÃn, J.; Madera, J.; Pascual, J.; González-Quintanilla, V.
Real-World Lessons with Fremanezumab as the Third Available CGRP Monoclonal Antibody in a Third-Level Hospital: Focus on the Factors Predicting Response. J. Clin. Med. 2025, 14, 1054.
https://doi.org/10.3390/jcm14041054
AMA Style
Polanco M, Gárate G, Sánchez-GudÃn J, Madera J, Pascual J, González-Quintanilla V.
Real-World Lessons with Fremanezumab as the Third Available CGRP Monoclonal Antibody in a Third-Level Hospital: Focus on the Factors Predicting Response. Journal of Clinical Medicine. 2025; 14(4):1054.
https://doi.org/10.3390/jcm14041054
Chicago/Turabian Style
Polanco, Marcos, Gabriel Gárate, Julia Sánchez-GudÃn, Jorge Madera, Julio Pascual, and Vicente González-Quintanilla.
2025. "Real-World Lessons with Fremanezumab as the Third Available CGRP Monoclonal Antibody in a Third-Level Hospital: Focus on the Factors Predicting Response" Journal of Clinical Medicine 14, no. 4: 1054.
https://doi.org/10.3390/jcm14041054
APA Style
Polanco, M., Gárate, G., Sánchez-GudÃn, J., Madera, J., Pascual, J., & González-Quintanilla, V.
(2025). Real-World Lessons with Fremanezumab as the Third Available CGRP Monoclonal Antibody in a Third-Level Hospital: Focus on the Factors Predicting Response. Journal of Clinical Medicine, 14(4), 1054.
https://doi.org/10.3390/jcm14041054
